Form 8-K - Current report:
SEC Accession No. 0001104659-23-063704
Filing Date
2023-05-24
Accepted
2023-05-23 18:07:25
Documents
12
Period of Report
2023-05-22
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2316619d1_8k.htm   iXBRL 8-K 33007
  Complete submission text file 0001104659-23-063704.txt   206949

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA inva-20230522.xsd EX-101.SCH 3021
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20230522_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20230522_pre.xml EX-101.PRE 22587
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2316619d1_8k_htm.xml XML 3604
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 23950075
SIC: 2834 Pharmaceutical Preparations